Drugs / PF-06881894
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05194579 | Feb → Aug 2022 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT03273842 | Oct 2017 → Jul 2018 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06881894 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05194579 ↗ |
| Route | Subcutaneous | “multiple subcutaneous doses” PMID 32524499 ↗ Jun 2020 |